146 related articles for article (PubMed ID: 35792806)
21. Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients.
Haroon S; Hashmi AA; Khurshid A; Kanpurwala MA; Mujtuba S; Malik B; Faridi N
Asian Pac J Cancer Prev; 2013; 14(7):4353-8. PubMed ID: 23992002
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.
Yagi T; Inoue N; Yanai A; Murase K; Imamura M; Miyagawa Y; Enomoto Y; Nishimukai A; Takatsuka Y; Hirota S; Akazawa K; Miyoshi Y
Breast Cancer; 2016 Mar; 23(2):224-30. PubMed ID: 25082658
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of RAD51 expression is associated with progression of thyroid carcinoma.
Sarwar R; Sheikh AK; Mahjabeen I; Bashir K; Saeed S; Kayani MA
Exp Mol Pathol; 2017 Jun; 102(3):446-454. PubMed ID: 28502582
[TBL] [Abstract][Full Text] [Related]
24. Correlation between expression of LRP16, Ki67 and EGFR and breast cancer clinical pathologic factors and prognosis.
Yao DJ; Qiao S; Zhang Y; Zhao YT; Yuan CH
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(3 Suppl):47-51. PubMed ID: 28745792
[TBL] [Abstract][Full Text] [Related]
25. Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy.
Khoo VS; Pollack A; Cowen D; Joon DL; Patel N; Terry NH; Zagars GK; von Eschenbach AC; Meistrich ML; Troncoso P
Prostate; 1999 Nov; 41(3):166-72. PubMed ID: 10517874
[TBL] [Abstract][Full Text] [Related]
26. [Ki67 in the prognosis of prostate cancer].
Huang T; Liu JJ; Zhang JW; Zhu ZC; Wang T; Cai L; Chen ZQ
Zhonghua Nan Ke Xue; 2019 Dec; 25(12):1088-1092. PubMed ID: 32251559
[TBL] [Abstract][Full Text] [Related]
27. Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors.
Nariculam J; Freeman A; Bott S; Munson P; Cable N; Brookman-Amissah N; Williamson M; Kirby RS; Masters J; Feneley M
Asian J Androl; 2009 Jan; 11(1):109-18. PubMed ID: 19050681
[TBL] [Abstract][Full Text] [Related]
28. Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancer.
Patel R; Hovstadius M; Kier MW; Moshier EL; Zimmerman BS; Cascetta K; Jaffer S; Sparano JA; Tiersten A
Cancer; 2022 Oct; 128(20):3602-3609. PubMed ID: 35947048
[TBL] [Abstract][Full Text] [Related]
29. DNA-PKcs expression predicts response to radiotherapy in prostate cancer.
Bouchaert P; Guerif S; Debiais C; Irani J; Fromont G
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1179-85. PubMed ID: 22494583
[TBL] [Abstract][Full Text] [Related]
30. Correlation of securin and Ki67 in invasive breast carcinoma.
Talaat IM; Hamoudi RA; Yakout NM; Oweiss NY; Omar AM
Histol Histopathol; 2019 Jun; 34(6):697-709. PubMed ID: 30506545
[TBL] [Abstract][Full Text] [Related]
31. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
Yamamoto S; Ibusuki M; Yamamoto Y; Fu P; Fujiwara S; Murakami K; Iwase H
Breast Cancer; 2013 Jul; 20(3):262-70. PubMed ID: 22362219
[TBL] [Abstract][Full Text] [Related]
32. [Expressions of Ki67, PCNA and mitotic index in ovarian epithelial tumors].
Wang S; Ma XY; Xia Y; Zhang LH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):575-80. PubMed ID: 20848772
[TBL] [Abstract][Full Text] [Related]
33. Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.
Azrad M; Zhang K; Vollmer RT; Madden J; Polascik TJ; Snyder DC; Ruffin MT; Moul JW; Brenner D; Hardy RW; Demark-Wahnefried W
PLoS One; 2012; 7(12):e53104. PubMed ID: 23285256
[TBL] [Abstract][Full Text] [Related]
34. Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer.
Sun JZ; Chen C; Jiang G; Tian WQ; Li Y; Sun SR
Int J Nanomedicine; 2014; 9():1339-46. PubMed ID: 24648732
[TBL] [Abstract][Full Text] [Related]
35. Investigation of c-KIT and Ki67 expression in normal, preneoplastic and neoplastic canine prostate.
Fonseca-Alves CE; Kobayashi PE; Palmieri C; Laufer-Amorim R
BMC Vet Res; 2017 Dec; 13(1):380. PubMed ID: 29207991
[TBL] [Abstract][Full Text] [Related]
36. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
[TBL] [Abstract][Full Text] [Related]
37. Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x.
Pollack A; Cowen D; Troncoso P; Zagars GK; von Eschenbach AC; Meistrich ML; McDonnell T
Cancer; 2003 Apr; 97(7):1630-8. PubMed ID: 12655519
[TBL] [Abstract][Full Text] [Related]
38. Aberrant Kif2a and Ki67 expression predicts poor survival in laryngeal squamous cell carcinoma.
Zhang Q; Zhang W; Zhang J; Xu H; You Y
Auris Nasus Larynx; 2016 Aug; 43(4):433-9. PubMed ID: 26602436
[TBL] [Abstract][Full Text] [Related]
39. Determining the prognostic significance of IKKα in prostate cancer.
Montes M; MacKenzie L; McAllister MJ; Roseweir A; McCall P; Hatziieremia S; Underwood MA; Boyd M; Paul A; Plevin R; MacKay SP; Edwards J
Prostate; 2020 Oct; 80(14):1188-1202. PubMed ID: 33258506
[TBL] [Abstract][Full Text] [Related]
40. Cutoff of 25% for Ki67 expression is a good classification tool for prognosis in colorectal cancer in the AJCC‑8 stratification.
Tong G; Zhang G; Liu J; Zheng Z; Chen Y; Niu P; Xu X
Oncol Rep; 2020 Apr; 43(4):1187-1198. PubMed ID: 32323802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
